Rabeprazole is effective in treating laryngopharyngeal reflux in a randomized placebo-controlled trial.
Lam
Paul K Y
PK
Department of Surgery, University of Hong Kong, Hong Kong, China.
Ng
Manwa L
ML
Cheung
Ting K
TK
Wong
Birgitta Y H
BY
Tan
Victoria P Y
VP
Fong
Daniel Y T
DY
Wei
William I
WI
Wong
Benjamin C Y
BC
D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000008:administration & dosage*; D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D057045:Laryngopharyngeal Reflux / Q000188:drug therapy* / Q000473:pathology; D007828:Laryngoscopy; D008297:Male; D008875:Middle Aged; D010919:Placebos / Q000008:administration & dosage; D054328:Proton Pump Inhibitors / Q000008:administration & dosage*; D064750:Rabeprazole; D012720:Severity of Illness Index; D049489:Stroboscopy; D011795:Surveys and Questionnaires; D016896:Treatment Outcome; D014743:Videotape Recording
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D010919:Placebos; D054328:Proton Pump Inhibitors; D064750:Rabeprazole